Why Buyers Discount Medical Practice Sales

Mike

It starts with an unexpected phone call or a remarkably polite letter landing on a clinic director's desk. Private equity firms, strategic health systems, sometimes even insurance-backed giants--they are all aggressively knocking on the doors of independent specialty practices. Cardiology, GI, orthopedics, urology... you name it, they want to buy it.

Claire Brooks

Right, and if you are a busy physician-owner who has spent, what, twenty or thirty years building a reputable clinic, receiving an unsolicited multi-million-dollar Letter of Intent feels like... well, like you have finally made it. It looks like a straight, uncomplicated highway to a comfortable exit. But, uh, as Miriam Ashore points out, that initial offer is often little more than a, you know, a very attractive piece of bait.

Mike

Exactly. Miriam is the founder of Ashore Healthcare Growth Advisors, and she is quite direct about this. The core misunderstanding is confusing clinical success with transaction value. You can have a practice that provides world-class patient care, has a stellar reputation in the community, and has pristine clinical outcomes. But to a sophisticated institutional buyer? That clinical excellence is merely the prerequisite. During due diligence, they are not auditing your surgical technique; they are auditing your operational maturity, your financial pipelines, and your structural risk.

Claire Brooks

Right, because the buyer's ultimate goal in due diligence is to find... uh, what do we call them? Risk factors. They want to find problems they can use to either chip away at that initial headline price or alter the structure of the deal--like pushing more of your payout into escrow or tying it to crazy post-sale performance metrics.

Mike

Precisely. They want to shift the risk back onto the physician. And this is why Miriam insists that the time to prepare for a sale is absolutely not when a buyer calls you. You need a solid twelve to twenty-four month runway of focused internal preparation before you even think about picking up the phone to talk to a buyer. Trying to clean up your books and restructure your workflows under the clock, with a buyer's legal team breathing down your neck? It is a recipe for leaving millions on the table.

Claire Brooks

So let us pull back the curtain on this due diligence machine. Miriam maps this out across five specific dimensions of practice valuation that buyers dissect. And the first one is financial performance, but it is not just "how much money did you make last year." It is about consistency and... what did she call it? Revenue concentration?

Mike

Yes, concentration risk. If seventy or eighty percent of your practice's revenue is generated by a single superstar surgeon, or if it comes from one specific insurance payer, or a single high-volume procedure... that is a massive red flag for a buyer. They look at that and think, "If that one doctor retires, or if that payer cuts their reimbursement rates, this business collapses." They will systematically discount your valuation to protect themselves from that single point of failure.

Claire Brooks

Oh, that makes total sense. And she also mentioned Medicare structure, right? Like, are you actually capturing modern Medicare revenue streams like Chronic Care Management--CCM--or Remote Patient Monitoring? If you are not doing that, a buyer sees a practice that is, you know, leaving easy money on the table, and they will value you accordingly.

Mike

Indeed. They will discount your price because they know they will have to spend the time and capital to build those clinical capabilities themselves post-acquisition. Now, the second dimension is operational efficiency, and this is where many legacy practices stumble. Buyers want to see that your business runs on documented, repeatable systems--not on the tribal knowledge trapped in your staff's heads.

Claire Brooks

Oh, I can picture that. The practice where "Brenda at the front desk" is the only person in the entire building who knows how to handle pre-authorizations or how to nudge a specific difficult payer. If Brenda decides to retire or go work for a competitor, the entire administrative engine grinds to a halt!

Mike

Quite right. That is a massive key-person dependency, which brings us to the third dimension: referral concentration. If your incoming patient flow is built entirely on the personal, handshake relationships of one senior physician, the buyer is going to ask: what happens when that physician leaves? Do those referrals evaporate?

Claire Brooks

Right. You have to build a diversified, institutional referral network so the clinic's brand, rather than a single personality, is drawing in the patients. Which naturally feeds into the fourth dimension: your growth trajectory. Buyers are buying the future, not the past. They want to see consistent upward trends in new patient acquisition and, crucially, patient retention. If your patient churn is high, your future revenue looks incredibly fragile.

Mike

And finally, there is the fifth dimension: compliance posture and documentation quality. This is where deals go to die. Sophisticated buyers will run detailed audits on your billing history, your coding accuracy, HIPAA compliance, and your clinical documentation. If they find sloppy charting or systemic billing errors, they do not just see a minor mistake. They see a massive regulatory liability that could trigger future federal audits or clawbacks, and they will either slash their offer or walk away entirely.

Claire Brooks

It is a total mismatch, honestly. You have got these highly sophisticated private equity groups who have done hundreds of these acquisitions, and on the other side, you have a physician who is trying to sell a business for the very first time. And the buyers use some really specific tactics, don't they? Like creating this false sense of extreme urgency with short-deadline Letters of Intent.

Mike

Absolutely. It is a classic high-pressure sales tactic. "Sign this LOI within forty-eight hours or this incredible premium offer is off the table forever." It is designed to panic the physician into signing a binding exclusivity agreement before they can seek outside counsel or understand what their practice is actually worth on the open market. And let us be clear: not all buyers are the same. A strategic health system, a large multi-specialty group, and a private equity consolidator all have vastly different deal structures, cultural expectations, and integration plans.

Claire Brooks

So, how do you level the playing field? Miriam's firm has this four-week "Transaction Readiness and Strategic Positioning" framework. It is basically an intense diagnostic boot camp. Week one is all about assessing the financials and mapping out the operational profile to see where those hidden risks are. Then in week two, they actually score the practice across those five buyer dimensions we talked about.

Mike

Yes, and once you have that risk score, you can prioritize. If you have twelve to eighteen months, you can fix the high-impact, easy-to-remedy gaps first. Week three is about developing the "transaction narrative." You are shaping the story of your practice--framing your genuine strengths and positioning any weaknesses honestly, but in the best possible light. And finally, week four delivers a highly tactical, prioritized action plan with concrete steps to take immediately, in six months, and in the year leading up to a sale.

Claire Brooks

It is about going from a reactive state--where you are just responding to whatever a buyer throws at you--to a proactive state where you actually dictate the terms because you know your numbers, you know your worth, and you have built a business that can run smoothly without you. If you have spent thirty years building something valuable, you deserve to walk away with the full value of that legacy.

Mike

I couldn't agree more. If you are an independent owner facing these decisions, check out Miriam's work at ashore-healthcare-growth-advisors-llc.com. Alright, that is our time for today. Good chatting, Claire.

Claire Brooks

Yeah, great talking. See you next time.